
DMS IMAGING Stock Over 25% Up In The Last 10 Sessions
DMS Imaging, a Belgium-based biopharma company, has recently been under global spotlight due to its extraordinary performance. Despite the slump in the BEL 20 index by 0.62%, DMS experienced a promising 25 percent increase over a span of 10 sessions. The company’s strength lies in its specialization in immunotherapy products aimed at combating allergies. Currently,…